Clinical Study
Meet Steven Goldberg, MD, MBA: Chief Medical Officer
Dr. Steven Goldberg • Sep. 24, 2024
Dr. Steven Goldberg is a visionary healthcare leader recognized as one of the “100 Most Influential in Healthcare” by Modern Healthcare in 2020, ranking #39. With a strong commitment to population health and financial performance, he has established himself as a Chief Clinical Executive with a national reputation for excellence.
Dr. Goldberg has a proven track record of transforming clinical operations to contribute multimillion-dollar gains to organizational profitability through enhanced revenue, margin improvement, and clinical outcomes. He has successfully led large teams of up to 1,500 full-time employees, focusing on boosting employee engagement and morale while fostering a culture of mentorship and empowerment.
His strategic acumen shines in large, complex organizations where he drives initiatives that yield significant business results. An energetic and sought-after communicator, Dr. Goldberg combines a meticulous attention to detail with a collaborative approach, making him a respected figure in healthcare leadership.
Manuscripts
1. French AJ, Fragala MS, Evans A, Upadhyay P, Goldberg SE, Reddy J. Real world evaluation of next-day molecular respiratory infectious disease testing on healthcare resource utilization and costs. ClinicoEconomics and Outcomes Research 2024. (In review) (Impact Factor: 2.1)
2. Evans A, Doshi R, Yeaw J, Coyle K, Steven Goldberg SE, Wang E, Fragala MS, Reddy J. Healthcare resource utilization and costs among patients receiving diagnostic tests for respiratory infections. American Journal of Managed Care 2024. (In review) (Impact Factor: 3.2)
3. Alexander BD, Hanson KE, Rosato AE, Nash DB, Fragala MS, Goldberg SE. Critical Need for Antibiotic Stewardship in Urgent Care: Role of Emerging Molecular Diagnostics. Journal of Urgent Care Medicine 2024. (In revision)
4. Evans A, Singh V, Upadhyay P, Fragala MS, French AJ, Goldberg SE, Reddy J. Molecular Testing for Respiratory Tract Infections: Real-world Impact on Healthcare Costs. Am J Inf Dis 2024. (In revision) (Impact Factor: 3.1)
5. Alexander BD, Irish W, Rosato AE, Eisenstein BI, Fragala MS, Goldberg SE, Nash DB. Is Pathogen Molecular Testing Reshaping Outpatient Antibiotic Prescribing? American Journal of Medical Quality 2024. (In revision) (Impact Factor: 1.0)
6. Evans A, Doshi R, Yeaw J, Coyle K, Goldberg SE, Wang E, Fragala MS, Reddy J. Healthcare Utilization and Costs Following PCR Diagnostic Testing Among Patients with Vaginitis The Journal of Comparative Effectiveness Research 2024. (In press) (Impact Factor: 2.1)
7. Evans A, Singh V, Upadhyay P, Fragala MS, Upadhyay P, French AJ, Goldberg SE, Reddy J. Molecular Testing for Women’s Gynecologic Health: Real-World Impact on Health Care Costs. Population Health Management 2024. 2 October 2024. https://doi.org/10.1089/pop.2024.0133. (Impact Factor: 2.0)
8. Evans A, Fragala, MS, Upadhyay P, French AJ, Goldberg SE, Reddy J. Utilization of Syndromic Vaginitis Diagnostic Testing Reduces 6-Month Follow-Up Outpatient Service Healthcare Costs—A Real-World Data Analysis. Healthcare 2024, 12(22), 2204; https://doi.org/10.3390/healthcare12222204. (Impact Factor: 2.4)
9. Fragala MS, Keogh M, Goldberg SE, Lorenz RA, Shaman JA. Clinical and economic outcomes of a pharmacogenomics-enriched comprehensive medication management program in a self-insured employee population. Pharmacogenomics J 24, 30 (2024). https://doi.org/10.1038/s41397-024-00350-1. (Impact Factor: 13.8)
10. Goldberg SE, Fragala MS. Health Care Bricolage: A Method to Reduce High-Cost Medical Spend. Population Health Management. 2024. https://doi.org/10.1089/pop.2024.0008 (Impact Factor 2.5)
11. Haji-Sheikhi F, Fragala MS, Bare LA, Rowland CM, Goldberg SE. Prediction of Future Medical Costs by Modifiable Measures of Health. Clinicoecon Outcomes Res. 2023 Jun 30;15:525-534. (Impact Factor: 0.445)
12. Keogh M, Fragala MS, Peter AP, Lorenz RA, Goldberg SE, Shaman JA. Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee Population. J Occup Environ Med. 2022 Dec 1;64(12):e818-e822.
13. Fragala MS, Shaman JA, Lorenz RA, Goldberg SE. Role of Pharmacogenomics in Comprehensive Medication Management: Considerations for Employers. Popul Health Manag. 2022 Dec;25(6):753-762.
14. Fragala MS, Goldberg Z Goldberg, SE. Return to Work: Managing Employee Population Health During the COVID-19 Pandemic. Population Health Management. Manag. 2021 Feb;24(S1):S3-S15. (Impact Factor: 2.09)
15. Plantes PJ, Fragala MS, Clarke C, Goldberg ZN, Radcliff J, Goldberg SE. Model for Mitigation of Workplace Transmission of COVID-19 Through Population-Based Testing and Surveillance. Popul Health Manag. 2021 Feb;24(S1):S16-S25. (Impact Factor: 2.09)
16. Goldberg SE, Fragala MS, Wohlgemuth JG. Self-insured Employer Health Benefits Strategy Established a Negative Cost Trend While Improving Performance. Population Health Management. 2019 Dec;22(6):547-554. (Impact Factor: 1.26)
Related Articles and White papers
Dr. Steven Goldberg • Sep. 24, 2024
Dr. Steven Goldberg is a visionary healthcare leader recognized as one of the “100 Most Influential in Healthcare” by Modern Healthcare in 2020, ranking #39. With a strong commitment to population health and financial performance, he has established himself as a Chief Clinical Executive with a national reputation for excellence.
Dr. Goldberg has a proven track record of transforming clinical operations to contribute multimillion-dollar gains to organizational profitability through enhanced revenue, margin improvement, and clinical outcomes. He has successfully led large teams of up to 1,500 full-time employees, focusing on boosting employee engagement and morale while fostering a culture of mentorship and empowerment.
His strategic acumen shines in large, complex organizations where he drives initiatives that yield significant business results. An energetic and sought-after communicator, Dr. Goldberg combines a meticulous attention to detail with a collaborative approach, making him a respected figure in healthcare leadership.
Manuscripts
1. French AJ, Fragala MS, Evans A, Upadhyay P, Goldberg SE, Reddy J. Real world evaluation of next-day molecular respiratory infectious disease testing on healthcare resource utilization and costs. ClinicoEconomics and Outcomes Research 2024. (In review) (Impact Factor: 2.1)
2. Evans A, Doshi R, Yeaw J, Coyle K, Steven Goldberg SE, Wang E, Fragala MS, Reddy J. Healthcare resource utilization and costs among patients receiving diagnostic tests for respiratory infections. American Journal of Managed Care 2024. (In review) (Impact Factor: 3.2)
3. Alexander BD, Hanson KE, Rosato AE, Nash DB, Fragala MS, Goldberg SE. Critical Need for Antibiotic Stewardship in Urgent Care: Role of Emerging Molecular Diagnostics. Journal of Urgent Care Medicine 2024. (In revision)
4. Evans A, Singh V, Upadhyay P, Fragala MS, French AJ, Goldberg SE, Reddy J. Molecular Testing for Respiratory Tract Infections: Real-world Impact on Healthcare Costs. Am J Inf Dis 2024. (In revision) (Impact Factor: 3.1)
5. Alexander BD, Irish W, Rosato AE, Eisenstein BI, Fragala MS, Goldberg SE, Nash DB. Is Pathogen Molecular Testing Reshaping Outpatient Antibiotic Prescribing? American Journal of Medical Quality 2024. (In revision) (Impact Factor: 1.0)
6. Evans A, Doshi R, Yeaw J, Coyle K, Goldberg SE, Wang E, Fragala MS, Reddy J. Healthcare Utilization and Costs Following PCR Diagnostic Testing Among Patients with Vaginitis The Journal of Comparative Effectiveness Research 2024. (In press) (Impact Factor: 2.1)
7. Evans A, Singh V, Upadhyay P, Fragala MS, Upadhyay P, French AJ, Goldberg SE, Reddy J. Molecular Testing for Women’s Gynecologic Health: Real-World Impact on Health Care Costs. Population Health Management 2024. 2 October 2024. https://doi.org/10.1089/pop.2024.0133. (Impact Factor: 2.0)
8. Evans A, Fragala, MS, Upadhyay P, French AJ, Goldberg SE, Reddy J. Utilization of Syndromic Vaginitis Diagnostic Testing Reduces 6-Month Follow-Up Outpatient Service Healthcare Costs—A Real-World Data Analysis. Healthcare 2024, 12(22), 2204; https://doi.org/10.3390/healthcare12222204. (Impact Factor: 2.4)
9. Fragala MS, Keogh M, Goldberg SE, Lorenz RA, Shaman JA. Clinical and economic outcomes of a pharmacogenomics-enriched comprehensive medication management program in a self-insured employee population. Pharmacogenomics J 24, 30 (2024). https://doi.org/10.1038/s41397-024-00350-1. (Impact Factor: 13.8)
10. Goldberg SE, Fragala MS. Health Care Bricolage: A Method to Reduce High-Cost Medical Spend. Population Health Management. 2024. https://doi.org/10.1089/pop.2024.0008 (Impact Factor 2.5)
11. Haji-Sheikhi F, Fragala MS, Bare LA, Rowland CM, Goldberg SE. Prediction of Future Medical Costs by Modifiable Measures of Health. Clinicoecon Outcomes Res. 2023 Jun 30;15:525-534. (Impact Factor: 0.445)
12. Keogh M, Fragala MS, Peter AP, Lorenz RA, Goldberg SE, Shaman JA. Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee Population. J Occup Environ Med. 2022 Dec 1;64(12):e818-e822.
13. Fragala MS, Shaman JA, Lorenz RA, Goldberg SE. Role of Pharmacogenomics in Comprehensive Medication Management: Considerations for Employers. Popul Health Manag. 2022 Dec;25(6):753-762.
14. Fragala MS, Goldberg Z Goldberg, SE. Return to Work: Managing Employee Population Health During the COVID-19 Pandemic. Population Health Management. Manag. 2021 Feb;24(S1):S3-S15. (Impact Factor: 2.09)
15. Plantes PJ, Fragala MS, Clarke C, Goldberg ZN, Radcliff J, Goldberg SE. Model for Mitigation of Workplace Transmission of COVID-19 Through Population-Based Testing and Surveillance. Popul Health Manag. 2021 Feb;24(S1):S16-S25. (Impact Factor: 2.09)
16. Goldberg SE, Fragala MS, Wohlgemuth JG. Self-insured Employer Health Benefits Strategy Established a Negative Cost Trend While Improving Performance. Population Health Management. 2019 Dec;22(6):547-554. (Impact Factor: 1.26)